Literature DB >> 29135354

Depression following traumatic brain injury in mice is associated with down-regulation of hippocampal astrocyte glutamate transporters by thrombin.

Chun-Shu Piao1,2, Ashley L Holloway1,2, Sue Hong-Routson1,2,3, Mark S Wainwright1,2,3.   

Abstract

Depression after traumatic brain injury (TBI) is common but the mechanisms by which TBI causes depression are unknown. TBI decreases glutamate transporters GLT-1 and GLAST and allows extravasation of thrombin. We examined the effects of thrombin on transporter expression in primary hippocampal astrocytes. Application of a PAR-1 agonist caused down-regulation of GLT-1, which was prevented by inhibition of Rho kinase (ROCK). To confirm these mechanisms in vivo, we subjected mice to closed-skull TBI. Thrombin activity in the hippocampus increased one day following TBI. Seven days following TBI, expression of GLT-1 and GLAST was reduced in the hippocampus, and this was prevented by administration of the PAR-1 antagonist SCH79797. Inhibition of ROCK attenuated the decrease in GLT-1, but not GLAST, after TBI. We measured changes in glutamate levels in the hippocampus seven days after TBI using an implanted biosensor. Stress-induced glutamate levels were significantly increased following TBI and this was attenuated by treatment with the ROCK inhibitor fasudil. We quantified depressive behavior following TBI and found that inhibition of PAR-1 or ROCK decreased these behaviors. These results identify a novel mechanism by which TBI results in down-regulation of astrocyte glutamate transporters and implicate astrocyte and glutamate transporter dysfunction in depression following TBI.

Entities:  

Keywords:  Astrocyte; depression; glutamate transporter; thrombin; traumatic brain injury

Mesh:

Substances:

Year:  2017        PMID: 29135354      PMCID: PMC6311670          DOI: 10.1177/0271678X17742792

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  61 in total

1.  Rates of major depressive disorder and clinical outcomes following traumatic brain injury.

Authors:  Charles H Bombardier; Jesse R Fann; Nancy R Temkin; Peter C Esselman; Jason Barber; Sureyya S Dikmen
Journal:  JAMA       Date:  2010-05-19       Impact factor: 56.272

2.  Blood-brain barrier disruption in post-traumatic epilepsy.

Authors:  O Tomkins; I Shelef; I Kaizerman; A Eliushin; Z Afawi; A Misk; M Gidon; A Cohen; D Zumsteg; A Friedman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-11-08       Impact factor: 10.154

3.  NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test.

Authors:  Mehdi Ghasemi; Laleh Montaser-Kouhsari; Hamed Shafaroodi; Behtash Ghazi Nezami; Farzad Ebrahimi; Ahmad Reza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2009-07-16       Impact factor: 4.530

4.  Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder.

Authors:  Adriana Medina; Sharon Burke; Robert C Thompson; William Bunney; Richard M Myers; Alan Schatzberg; Huda Akil; Stanley J Watson
Journal:  J Psychiatr Res       Date:  2013-05-24       Impact factor: 4.791

5.  Natural history of depression in traumatic brain injury.

Authors:  Sureyya S Dikmen; Charles H Bombardier; Joan E Machamer; Jesse R Fann; Nancy R Temkin
Journal:  Arch Phys Med Rehabil       Date:  2004-09       Impact factor: 3.966

6.  The tail suspension test: a new method for screening antidepressants in mice.

Authors:  L Steru; R Chermat; B Thierry; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes.

Authors:  Zeev Itsekson-Hayosh; Efrat Shavit-Stein; Aviva Katzav; Vardit Rubovitch; Nicola Maggio; Joab Chapman; Sagi Harnof; Chaim G Pick
Journal:  J Neurotrauma       Date:  2016-02-17       Impact factor: 5.269

8.  Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage.

Authors:  Shin-Ichi Satoh; Asako Hitomi; Ichiro Ikegaki; Koh Kawasaki; Osamu Nakazono; Masakazu Iwasaki; Mitsunobu Mohri; Toshio Asano
Journal:  Brain Res Bull       Date:  2010-01-15       Impact factor: 4.077

9.  Hypoxia suppresses glutamate transport in astrocytes.

Authors:  Mark Dallas; Hannah E Boycott; Lucy Atkinson; Alison Miller; John P Boyle; Hugh A Pearson; Chris Peers
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

10.  Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial.

Authors:  Ricardo E Jorge; Laura Acion; Debora I Burin; Robert G Robinson
Journal:  JAMA Psychiatry       Date:  2016-10-01       Impact factor: 21.596

View more
  13 in total

1.  Roles of Prokineticin 2 in Subarachnoid Hemorrhage-Induced Early Brain Injury via Regulation of Phenotype Polarization in Astrocytes.

Authors:  Mian Ma; Haiying Li; Jiang Wu; Yunhai Zhang; Haitao Shen; Xiang Li; Zhong Wang; Gang Chen
Journal:  Mol Neurobiol       Date:  2020-06-22       Impact factor: 5.590

Review 2.  Effectiveness of Pharmacotherapy for Depression after Adult Traumatic Brain Injury: an Umbrella Review.

Authors:  Amelia J Hicks; Fiona J Clay; Amelia C James; Malcolm Hopwood; Jennie L Ponsford
Journal:  Neuropsychol Rev       Date:  2022-06-14       Impact factor: 7.444

Review 3.  Cells of the Blood-Brain Barrier: An Overview of the Neurovascular Unit in Health and Disease.

Authors:  Heather L McConnell; Anusha Mishra
Journal:  Methods Mol Biol       Date:  2022

Review 4.  TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications.

Authors:  Jian Luo
Journal:  Biomedicines       Date:  2022-05-23

Review 5.  Glutamate Efflux across the Blood-Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System.

Authors:  Benjamin Fredrick Gruenbaum; Alexander Zlotnik; Amit Frenkel; Ilya Fleidervish; Matthew Boyko
Journal:  Metabolites       Date:  2022-05-20

Review 6.  Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression.

Authors:  José Javier Miguel-Hidalgo
Journal:  Front Cell Neurosci       Date:  2022-04-22       Impact factor: 6.147

7.  Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture.

Authors:  Cen Yang; Jingjing Liu; Jingyi Wang; Anqi Yin; Zhenhua Jiang; Shuwei Ye; Xue Liu; Xia Zhang; Feng Wang; Lize Xiong
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-04       Impact factor: 6.200

Review 8.  Preclinical Models of Traumatic Brain Injury: Emerging Role of Glutamate in the Pathophysiology of Depression.

Authors:  Darik A O'Neil; Melissa A Nicholas; Naima Lajud; Anthony E Kline; Corina O Bondi
Journal:  Front Pharmacol       Date:  2018-06-01       Impact factor: 5.810

Review 9.  Role of Thrombin in Central Nervous System Injury and Disease.

Authors:  Nathan A Shlobin; Meirav Har-Even; Ze'ev Itsekson-Hayosh; Sagi Harnof; Chaim G Pick
Journal:  Biomolecules       Date:  2021-04-12

10.  Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-κB Signaling.

Authors:  Jianing Luo; Xun Wu; Haixiao Liu; Wenxing Cui; Wei Guo; Kang Guo; Hao Guo; Kai Tao; Fei Li; Yingwu Shi; Dayun Feng; Hao Yan; Guodong Gao; Yan Qu
Journal:  Neurosci Bull       Date:  2020-10-27       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.